8-K
filed April 26, 2024, 7:59 PM ET
ticker AVAI
CIK 0001740797
leadership
confidence high
sentiment neutral
materiality 0.50
Avant Technologies CEO & COO resign; William Hisey named Interim CEO
AVAI BIO, INC.
- Timothy Lantz resigned as CEO and Director effective April 24, 2024, without conflicts with the Board.
- Angela Harris resigned as COO and Jared Pelski as VP Business Development, effective April 24, 2024.
- William Hisey appointed Interim CEO effective April 25, 2024; base salary $4,000/month plus quarterly RSA of 70,000 shares.
- All three prior employment agreements (Lantz, Pelski, Harris) canceled by mutual consent; no claims outstanding.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Timothy Lantz resigned as Director at AVAI BIO, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jared Pelski resigned as Vice President – Business Development at AVAI BIO, INC..
- Action
- resigned
- Role
- Vice President – Business Development
Exact text from the filing
Effective April 24, 2024, Jared Pelski resigned as Vice President – Business Development of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Timothy Lantz resigned as Chief Executive Officer at AVAI BIO, INC..
- Action
- resigned
- Role
- Chief Executive Officer
Exact text from the filing
Effective April 24, 2024, Mr. Lantz vacated his positions as CEO and Director of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Hisey was appointed as Interim Chief Executive Officer at AVAI BIO, INC..
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
William Hisey – Interim CEO Appointment: On April 24, 2024, Avant Technologies, Inc. (the 'Company') and William Hisey entered into an Employment Agreement pursuant to which Mr. Hisey was retained as Interim Chief Executive Officer ('CEO').
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Angela Harris resigned as Chief Operating Officer at AVAI BIO, INC..
- Action
- resigned
- Role
- Chief Operating Officer
Exact text from the filing
Effective April 24, 2024, Angela Harris resigned as Chief Operating Officer ('COO') of the Company.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.